Efficacy and treatment satisfaction with on-demand tadalafil (Cialis ®) in men with erectile dysfunction

European Urology

Volumn 46, Issue 3, 2004, Pages 362-369

  Skoumal, René ^a   Chen, Juza ^b   Kula, Krzysztof ^c   Breza, Jan ^d   Calomfirescu, Nicolae ^e   Basson, Bruce R ^f   Kopernicky, Vladimir ^f  

^a Urocentrum Brno   (Czech Republic)

^b TEL AVIV UNIVERSITY   (Israel)

^c MEDICAL UNIVERSITY OF LODZ   (Poland)

^d Urologicka Klinika Fnsp L Derera   (Slovakia)

^e Uro Andro Med   (Romania)

^f ELI LILLY AND COMPANY   (United States)

Author keywords

Cialis ; Erectile dysfunction; Patient satisfaction; Tadalafil

Indexed keywords

PLACEBO; SILDENAFIL; TADALAFIL;

ADULT; AGED; ARTICLE; BACKACHE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DATA ANALYSIS; DEMOGRAPHY; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; ERECTILE DYSFUNCTION; EVALUATION; FLUSHING; HEADACHE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PATIENT SATISFACTION; PRIORITY JOURNAL; QUESTIONNAIRE; RANDOMIZATION; RANDOMIZED CONTROLLED TRIAL; SCORING SYSTEM; SIDE EFFECT; STATISTICAL SIGNIFICANCE; VALIDATION PROCESS; WILCOXON SIGNED RANKS TEST;

EID: 4043144910     PISSN: 03022838     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.eururo.2004.04.026     Document Type: Article

References (14)

1. NIH Consensus Development Panel on Impotence. Impotence. JAMA 1993;270:83-90.
2. Kubin M., Wagner G., Fugl-Meyer A.R. Epidemiology of erectile dysfunction. Int. J. Impot. Res. 15:2003;63-71
3. Jarow F.P., Nana-Sinkam P., Sabbagh M., Eskew A. Outcome analysis of goal directed therapy of impotence. J. Urol. 155:1996;1609-1612
4. Goldstein I., Lue T.F., Padma-Nathan H., Rosen R.C., Steers W.D., Wicker P.A. Oral sildenafil in the treatment of erectile dysfunction. N. Engl. J. Med. 338:1998;1397-1404
5. Hellstrom W.J.G., Gittelman M., Karlin G., Segerson T., Thibonnier M., Taylor T., et al. Vardenafil for treatment of men with erectile dysfunction: efficacy and safety in a randomized, double-blind, placebo-controlled trial. J. Androl. 23:2002;763-771
6. Brock G.B., McMahon C.G., Chen K.K., Costigan T., Shen W., Watkins V., et al. Efficacy and safety of tadalafil for the treatment of erectile dysfunction: results of integrated analyses. J. Urol. 168:2002;1332-1336
7. Porst H., Padma-Nathan H., Giuliano F., Anglin G., Varanese L., Rosen R. Efficacy of tadalafil for the treatment of erectile dysfunction at 24 and 36 hours after dosing: a randomized controlled trial. Urology. 62:2003;121-126
8. Saenz de Tajada I., Goldstein I., Azadzoi K., Krane R.J., Cohen R.A. Impaired neurogenic and endothelium-mediated relaxation of penile smooth muscle from diabetic men with impotence. N. Engl. J. Med. 320:1989;1025-1030
9. Shabsigh R., Fishman I.J., Schum C., Dunn J.K. Cigarette smoking and other risk factors in vasculogenic impotence. Urology. 38:1991;227-231
10. Althof S.E., Corty E.W., Levine S.B., Levine F., Burnett A.L., McVary K., et al. EDITS: development of questionnaires for evaluating satisfaction with treatments for erectile dysfunction. Urology. 53:1999;793-799
11. Rosen R.C., Riley A., Wagner G., Osterloh I.H., Kirkpatrick J., Mishra A. The International Index of Erectile Function (IIEF): a multidimensional scale for assessment of erectile dysfunction. Urology. 49:1997;822-830
12. Lewis R., Bennett C.J., Borkon W.D., Boykin W.H., Althof S.E., Stecher V.J., et al. Patient and partner satisfaction with Viagra (sildenafil citrate) treatment as determined by the erectile dysfunction inventory of treatment satisfaction questionnaire. Urology. 57:2001;960-965
13. Saenz de Tajada I., Knight J.R., Anglin G., Emmick J.T. Effects of tadalafil on rectile dysfunction in men with diabetes. Diabetes Care. 25:2002;2159-2164
14. Padma-Nathan H, McMurray JG, Pullman WE, Whitaker JS, Saoud JB, Ferguson KM, Rosen RC for the IC351 on-demand dosing study group. On-demand IC351 (Cialis™) enhances erectile function in patients with erectile dysfunction. Int J Impot Res 2001;13:2-9.